(Total Views: 98)
Posted On: 07/21/2021 2:20:53 PM
Post# of 21237

$SRNE News Article - Sorrento Announces That Its Subsidiary Levena and Its Partner Escugen Have Received Clearance to Begin Clinical Trials With Anti-TROP-2 Antibody Drug Conjugate For Multiple Solid Tumors https://marketwirenews.com/news-releases/sorr...34111.html


My Twitter: WhyteStocks